Fig. 2
From: Design and clinical developments of aptamer-drug conjugates for targeted cancer therapy

(A) ApDC constructed by Nucleotide Analogs. (B) ApDC by drug and aptamer intercalation (C) ApDC by using linker between drug and an aptamer
From: Design and clinical developments of aptamer-drug conjugates for targeted cancer therapy
(A) ApDC constructed by Nucleotide Analogs. (B) ApDC by drug and aptamer intercalation (C) ApDC by using linker between drug and an aptamer